Ricerca Biosciences, a preclinical development contract research organisation (CRO) providing services to the biopharmaceutical industry, has appointed Douglas Fuhrer as the senior director of Drug Safety.
Subscribe to our email newsletter
Fuhrer has over 12 years experience directing teams of scientists and technicians in large pharmaceutical companies, biotech organisations and CROs.
Fuhrer has experience in therapeutic areas like anti-infectives, cancer, immune regulation, diabetes, CNS, prostate enlargement and hepatitis C.
Ricerca Concord, Ohio Drug Development Operations senior vice president and general manager Michael Placke said that Fuhrer possesses the experience and insights necessary to guide their preclinical drug development strategies.
Ricerca offers services for the areas of preclinical discovery and chemical synthesis development for pharmaceutical and biopharmaceutical products, as well as agrochemical and environmental registration.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.